Research Article
lncRNA LEF1-AS1 Acts as a Novel Biomarker and Promotes Hypopharyngeal Squamous Cell Carcinoma Progression and Metastasis by Targeting the miR-221-5p/GJA1 Axis
Figure 4
LEF1-AS1 acts as ceRNA to regulate the miR-221-5p expression. (a) Presentation of binding sites between LEF1-AS1 and miR-221-5p by RNA22 online tool. (b) Luciferase activity of LEF1-AS1-WT or LEF1-AS1-Mut plasmid in miR-221-5p overexpressed FaDu cells. (c) Anti-Ago2 RIP assay confirmed the combination between LEF1-AS1 and miR-221-5p. (d, e) Relative expression of miR-221-5p in LEF1-AS1 overexpressed (d) or silenced (e) FaDu cells. (f) The expression level of miR-221-5p in HNSCC tumor tissues () and normal tissues () from the TCGA database. (g) Kaplan–Meier curves revealed overall survival of HNSCC patients with high or low levels of miR-221-5p in TCGA. (h) Negative correlation between LEF1-AS1 and miR-221-5p in TCGA data. Data are presented as . ; ; .
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |